Q2 2024 Holdings
Filed 2024-08-14 | 1 holdings | $1.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-19) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $71.4M | 1,206,707 | 25.9% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $70.1M | 5,185,191 | 25.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $46.3M | 3,966,726 | 16.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $31.8M | 6,880,527 | 11.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $30.6M | 5,224,600 | 11.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $6.6M | 377,323 | 2.4% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $5.2M | 2,228,295 | 1.9% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $4.5M | 167,317 | 1.6% |
| Passage BIO Inc | COM | 702712100 | $4.0M | 5,057,629 | 1.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.7M | 492,103 | 1.3% |
| Ibio Inc(IBIO)A | CON NEW | 451033708 | $1.3M | 600,000 | 100.0% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $459.9K | 599,673 | 0.2% |
| Pieris Pharmaceuticals Inc | COM NEW | 720795202 | $426.8K | 43,499 | 0.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $177.4K | 9,500 | 0.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $157.1K | 17,400 | 0.1% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $128.7K | 3,800 | 0.0% |
| Vyne Therapeutics Inc(VYNE) | COM | 92941V308 | $31.9K | 16,194 | 0.0% |